Jonathan Bryan Lee, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A176180 · Current
Licensed to practise in California · since 2022 · expires 2028-04-30 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$129,114
Medicare paid this office $129,114 for 501 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 158 | $32,858 | $116 |
| New patient visit (60+ min) | 80 | $15,135 | $189 |
| Emergency department visit with high level of medical decision making | 96 | $14,170 | $146 |
| Botox | 13 | $14,005 | None |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 20 | $3,938 | $179 |
See all 24 services
| Return visit (30+ min) | 158 | $32,858 | $116 |
| New patient visit (60+ min) | 80 | $15,135 | $189 |
| Emergency department visit with high level of medical decision making | 96 | $14,170 | $146 |
| Botox | 13 | $14,005 | None |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 20 | $3,938 | $179 |
| Long return visit (40+ min) | 20 | $3,701 | $161 |
| Injection of trigger points, 3 or more muscles | 43 | $3,381 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $2,909 | $100 |
| Administration of psychological or neuropsychological test, first 30 minutes | 55 | $2,770 | $41 |
| Critical care, first 30-74 minutes | 15 | $2,592 | $173 |
| Emergency department visit with moderate level of medical decision making | 23 | $2,290 | $100 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 23 | $1,776 | $74 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 87 | $1,718 | $15 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 22 | $1,599 | $57 |
| Injection of substance into lower spine canal using imaging guidance | 19 | $1,526 | $80 |
| Short return visit (20+ min) | 19 | $1,522 | $80 |
| Destruction of peripheral nerve or branch | 12 | $1,422 | $118 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 17 | $1,098 | $58 |
| Aspiration and/or injection of fluid from large joint | 14 | $991 | $58 |
| Injection of trigger points, 1-2 muscles | 12 | $850 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $417 | $10 |
| Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | 13 | $372 | $29 |
| Injection, ropivacaine hydrochloride, 1 mg | 73 | $302 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $113 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
Who their Medicare patients are
501 Original Medicare patients in 2024. Average age 75 · Under 65 12% · 85 and older 19% · Women 65% · Also on Medicaid 30% · Health risk score 1.89. Sicker patients than 9 in 10 peers; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Coronary heart disease 36% · Diabetes 33% · Depression 33% · Chronic kidney disease 30% · Heart failure 25% · Atrial fibrillation 24% · Cancer 19% · COPD 16% · Stroke 12% · Dementia 9%.
The office billed $1,674,931, Medicare allowed $168,319 and paid $129,114; for 11,008 services of 64 kinds; $17,684 of it was for drugs given in the office and $111,430 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 501 | 11,008 | 75 | 1.89 | $1,674,931 | $129,114 |
| 2023 | 175 | 3,271 | 73 | 1.64 | $376,488 | $36,849 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (60+ min) | 48 | $9,871 | $206 |
| Return visit (30+ min) | 36 | $6,418 | $121 |
| Emergency department visit with high level of medical decision making | 17 | $2,415 | $142 |
| Long return visit (40+ min) | 11 | $1,743 | $158 |
| Injection of trigger points, 3 or more muscles | 27 | $1,716 | $54 |
| Administration of psychological or neuropsychological test, first 30 minutes | 29 | $1,466 | $42 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 16 | $1,198 | $75 |
| Telehealth originating site facility fee | 35 | $965 | $22 |
| Injection, ropivacaine hydrochloride, 1 mg | 37 | $129 | None |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $69 | $5 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $48 | None |
Medicaid work
$13,434 in 2024
Medicaid paid $13,434 for 176 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 110 | $11,686 |
| Return visit (30+ min) | 66 | $1,748 |
| 2024 | 176 | 2 | 28 | $13,434 |
| 2023 | 24 | 1 | 12 | $2,912 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 24 | $2,912 |
Drugs they prescribed that Part D paid
$10,923
Pharmacies billed $10,923 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (20 of 282) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%.
275 generic and fewer than 11 brand-name prescriptions · $10,923 in drug cost · 21 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 93 | $2,595 | $28 |
| Pregabalin | 30 | $671 | $22 |
| Celecoxib | 21 | $510 | $24 |
| Gabapentin | 29 | $422 | $15 |
| Hydrocodone-Acetaminophen | 12 | $173 | $14 |
See all 6 drugs
| Duloxetine | 93 | $2,595 | $28 |
| Pregabalin | 30 | $671 | $22 |
| Celecoxib | 21 | $510 | $24 |
| Gabapentin | 29 | $422 | $15 |
| Hydrocodone-Acetaminophen | 12 | $173 | $14 |
| Nortriptyline | 11 | $74 | $7 |
Year by year
| 2024 | 282 | 113 | 7% (20) | None | $10,923 |
| 2023 | 170 | 79 | None | None | $9,053 |
| 2022 | 72 | 55 | None | None | $1,776 |
| 2021 | 65 | 47 | 17% (11) | None | $1,165 |
| 2020 | 11 | None | 0% (0) | None | $1,000 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Duloxetine | 49 | $2,047 | $42 |
| Pregabalin | 18 | $1,716 | $95 |
| Celecoxib | 23 | $924 | $40 |
| Gabapentin | 13 | $195 | $15 |
Money from drug and device companies
$413 in 2025
| 2025 | 4 | 4 | None | $413 |
| 2024 | 3 | 3 | None | $233 |
| 2023 | 3 | 4 | None | $470 |
| 2022 | 3 | 3 | None | $335 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Solventum | Prevena | $174 | 1 payment
|
| Stryker | Gamma | $161 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $54 | 1 payment
|
| Eisai | Leqembi | $24 | 1 payment
|
See all 4 published payments
| Solventum | Meals · 2025-08-11 | Prevena | $174 |
| Vertex Pharmaceuticals | Meals · 2025-04-05 | Journavx | $54 |
| Eisai | Meals · 2025-03-11 | Leqembi | $24 |
| Stryker | Meals · 2025-03-05 | Gamma | $161 |
See earlier years (2024, 2023, 2022)
2024: $233
| Stryker | Gamma | $147 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $48 | 1 payment
|
| Averitas Pharma | Qutenza | $38 | 1 payment
|
2023: $470
| Medtronic | Vanta Adaptivestim | $387 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $65 | 1 payment
|
| Nevro | Senza | $18 | 1 payment
|
2022: $335
| Nalu Medical | Nalu Neurostimulation System | $135 | 1 payment
|
| NuVasive | None | $123 | 1 payment
|
| Nevro | Omnia | $78 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104385103
- Licence
- CA A176180California A176180: Current · expires 2028-04-30
- Trained
- University of California, Irvine, California College of Medicine, 2019
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2019-03-19
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 101 the City Dr S, Orange, CA, 92868
This office lists an electronic records connection.